Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 17 von 388
Revista colombiana de nefrología (En línea), 2017-06, Vol.4 (1), p.69-73
2017
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
How useful in the daily practice of nephrologists are the new antidiabetics with cadiovascular protection?
Ist Teil von
  • Revista colombiana de nefrología (En línea), 2017-06, Vol.4 (1), p.69-73
Ort / Verlag
Asociación Colombiana de Nefrología e Hipertensión Arterial
Erscheinungsjahr
2017
Beschreibungen/Notizen
  • Abstract In recent years, several new antidiabetic drugs have been developed, among which only two have demonstrated superiority in cardiovascular protection. They are liraglutide and empagliflozine, which belong, respectively, to GLP-1 RA and SGLT-2Í. These medications have also shown benefits in kidney protection. However, in a recent survey of the author among nephrologists in a large colombian city, it has been detected that most do not use these drugs. The greater resistance to the limitation in its use is due to the advanced stages of chronic kidney disease where they are contraindicated, but also to the anawareness of their potential benefits. In this regard, the nephrologists accepted they should learn more about these antidiabetic medicines, because the type of patient that is frequently attended in their consultation will undoubtly benefit, and considering they are obligated to handle the diabetic patient directly.
Sprache
Portugiesisch
Identifikatoren
ISSN: 2500-5006
eISSN: 2500-5006
DOI: 10.22265/acnef.4.1.265
Titel-ID: cdi_scielo_journals_S2500_50062017000100069

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX